Probing new propellants. Tools to help you fast track HFA transition and generic product development

Written By PY

Read OzUK and Ab Initio’s joint article on the characterisation of MDI formulations and how our advanced dissolution methodology can predict product performance and equivalence of next gen propellant formulations.

Article courtesy of Inhalation Magazine

PY
Previous

Meet with the Team at the “Exploring the Future of Inhalation Drug Delivery” Conference in Parma this September!
Next

Emerging trends in inhaled drug delivery